PMVP | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

1.29%

1 Month

-5.99%

3 Months

-12.29%

6 Months

-13.26%

1 Year

-78.98%

2 Year

-88.56%

Key data

Stock price

$1.58

P/E Ratio

0.00

DAY RANGE

N/A - N/A

EPS

$0.00

52 WEEK RANGE

$1.18 - $7.39

52 WEEK CHANGE

-$0.79

MARKET CAP

80.886 M

YIELD

N/A

SHARES OUTSTANDING

51.520 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

1.69

PUBLIC FLOAT

AVERAGE 10 VOLUME

$302,415

AVERAGE 30 VOLUME

$256,928

Company detail

CEO: David H. Mack
Region: US
Website: pmvpharma.com
Employees: 54
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

pmv pharmaceuticals, inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. its lead product candidate is pc14586, a small molecule that corrects and restores p53 function. the company also develops product candidates for p53 r273h hotspot mutation and other p53 hotspot mutations. pmv pharmaceuticals, inc. was formerly known as pj pharmaceuticals, inc. and changed to in july 2013. the company was founded in 2013 and is headquartered in cranbury, new jersey.

PMVP - PMV Pharmaceuticals Inc